I presented the principles of integrative medicine in oncology and shared my latest research on the role of Modified Citrus Pectin (MCP) in the prevention and treatment of cancer at an international oncology conference in Greece.
I recently discussed the principles of integrative medicine in
oncology and shared the latest research on the role of Modified Citrus Pectin
(MCP) in the treatment of cancer at an international oncology conference in
Rhodes, Greece. This conference, titled “The 16th World Congress on Advances in
Oncology and 14th International Symposium on Molecular Medicine,” brought
together hundreds of cancer researchers, oncologists and medical professionals
from around the world to share the latest information and advancements in the
treatment and prevention of cancer. The international event was organized by
the International Journal of Oncology, Oncology Reports, International
Journal of Molecular Medicine, and Molecular Medicine Reports, and
held in Rodos Palace Resort on the island of Rhodes, Greece. The scientific
program included presentations by scientists and medical doctors on topics in
genetics, immunology, experimental oncology and brain tumors, among others.
For this presentation, I drew upon my 25+ years of experience as an integrative
physician and researcher to discuss the energetic and philosophical principles
of integrative medicine in oncology and how to apply these principles to cancer
prevention and treatment. This included the latest body of research on Modified
Citrus Pectin and novel polybotanical formulas in suppressing the growth and
proliferation of cancer.
What is Integrative Medicine?
Integrative medicine is a patient-driven, unbiased and individualized form of
medicine that combines both conventional and holistic approaches to treat
people as a whole, rather than focusing solely on diseases and symptoms. It
emphasizes a partnership between the patient and the practitioner in the
healing process, to create individualized programs and promote the body's
inherent healing response.In my
presentation, I discussed how integrative medicine takes into account the whole
person - mind, body and spirit - to integrate both conventional and alternative
therapies into uniquely tailored health protocols. True integrative medicine
includes treatments and approaches that are synergistically combined for
clinical outcome that is greater than the sum of its parts. This can include a
combination of conventional drugs, exercise, supplements and nutrition - but it
is also the merging of analytical conceptual thinking with a limitless
‘non-conceptual’ open-mindedness where anything is possible. Such a balance
paves the way to true healing.
Research on Modified Citrus Pectin and Polybotanicals
I shared recent research on the role of Modified Citrus Pectin (MCP)
and polybotanicals in the treatment of cancer, and explained specifically how
MCP directly attacks cancer by binding to galectin-3 molecules (“sticky”
surface molecules that promote angiogenesis and metastasis) and blocking their
harmful effects, so cancer cells cannot spread and grow.
Over the last decade, a large body of peer-reviewed research has revealed that
many of our most serious health concerns are associated with elevated levels of
galectin-3 molecules. Modified Citrus Pectin - derived from citrus peels - is
the only proven natural galectin-3 inhibitor and thus offers a powerful and
all-natural way to address elevated galectin-3 for cancer, metastasis, and
other chronic life threatening illnesses.
How Does MCP Work?
Food-grade pectin is a complex carbohydrate, a soluble form of fiber, and is
not digested by humans. However, when citrus pectin is modified to reduce the
length of the fiber chains and the amount of bulky cross-linking side groups,
it can be made absorbable. As a result, MCP enters the circulatory system and
reaches targeted areas of the body. MCP is structurally a poly galacturonic
acid fiber, made up of glactose subunits, which has been shown to suppress
cancer growth and metastases in multiple preclinical and clinical studies. In
prostate cancer patients, MCP has been shown to increase the prostate-specific
antigen (PSA) doubling time, and has also been shown to increase the quality of
life in people with advanced stage cancers of multiple types of solid tumors.
The anticancer effects are attributed to MCP being a natural ligand for
galectin-3 molecules, inhibiting the over-expressed galectin-3 molecules that
are present on the surface of cancer cells and circulating in the blood.
Galectin-3 has been implicated in multiple pathological processes including
abnormal proliferation, angiogenesis, apoptosis, inflammation and fibrosis.
I also presented recent research on the successful treatment of highly
invasive, hormone-dependent and independent prostate and breast cancer cells
using MCP, a novel poly-botanical formula for prostate cancer and another
formula for breast cancer. These combinations significantly further enhanced
inhibition of the invasive behavior of breast and prostate cancer cells,
respectively.I concluded
my presentation with an explanation of the role of the botanical extract
Honokiol, and its synergistic effects in combination with polybotanicals,
chemotherapy agents and MCP for the treatment of cancer.
For more information about Modified Citrus Pectin, download a wellness guide at
www.mcpreport.com.
Dr. Isaac Eliaz, M.D., MS., L.Ac., has been a pioneer in integrative medicine since the early 1980s. He is a respected researcher, innovative product formulator, clinical practitioner, author and lecturer. Dr. Eliaz is widely regarded as the leading expert in the field of Modified Citrus Pectin research and has been using Modified Citrus Pectin in his clinical practice for over 15 years to treat a variety of conditions.
